Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea

BACKGROUND/AIMS: This nationwide, multicenter prospective randomized controlled trial aimed to compare the efficacy and safety of 10-day concomitant therapy (CT) and 10-day sequential therapy (ST) with 7-day clarithromycin-containing triple therapy (TT) as first-line treatment for Helicobacter pylor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gut Liver
Hauptverfasser: Kim, Beom Jin, Lee, Hyuk, Lee, Yong Chan, Jeon, Seong Woo, Kim, Gwang Ha, Kim, Hyun-Soo, Sung, Jae Kyu, Lee, Dong Ho, Kim, Heung Up, Park, Moo In, Choi, Il Ju, Yoon, Soon Man, Kim, Sang Wook, Baik, Gwang Ho, Lee, Ju Yup, Kim, Jin Il, Kim, Sang Gyun, Kim, Jayoun, Lee, Joongyup, Kim, Jae Gyu, Kim, Jae J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Editorial Office of Gut and Liver 2019
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6743805/
https://ncbi.nlm.nih.gov/pubmed/31505907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl19136
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge